114 related articles for article (PubMed ID: 8387399)
1. Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.
Saito H; Shimokata K; Yamamoto M; Saka H; Sakai S; Saito H
Cancer Chemother Pharmacol; 1993; 32(2):134-6. PubMed ID: 8387399
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
3. CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.
Sandler A; Blanke C; Monaco F; Carey MA; Ansari R; Fisher B; Spiridonidis CH; Einhorn L; Nichols C
Am J Clin Oncol; 1998 Jun; 21(3):294-7. PubMed ID: 9626802
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer.
Saito H; Shimokata K; Saka H; Yamamoto M; Ogasawara T; Nomura F; Sakai S; Iwata M; Murate T; Miyachi T
Cancer Chemother Pharmacol; 1993; 33(2):154-6. PubMed ID: 8261575
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer.
Blanke C; DeVore R; Shyr Y; Epstein B; Murray M; Hande K; Stewart S; Johnson D
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):111-6. PubMed ID: 9054884
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
[TBL] [Abstract][Full Text] [Related]
7. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Shepherd FA; Evans WK; Goss PE; Latreille J; Logan D; Maroun J; Stewart D; Warner E; Paul K
Semin Oncol; 1992 Feb; 19(1 Suppl 1):54-8. PubMed ID: 1329213
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
Klastersky J; Sculier JP; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R; Dabouis G
J Clin Oncol; 1989 Aug; 7(8):1087-92. PubMed ID: 2547028
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.
Lee JS; Scott C; Komaki R; Fossella FV; Dundas GS; McDonald S; Byhardt RW; Curran WJ
J Clin Oncol; 1996 Apr; 14(4):1055-64. PubMed ID: 8648357
[TBL] [Abstract][Full Text] [Related]
14. A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer.
Krook JE; Jett JR; Little C
Am J Clin Oncol; 1989 Apr; 12(2):114-7. PubMed ID: 2539716
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
Makimoto T; Tsuchiya S; Nakano H; Watanabe S; Minato K; Takise A; Ezawa K; Fueki N; Naruse I; Nomoto T; Takei Y; Ishihara S; Mori M; Saitoh R
Am J Clin Oncol; 1997 Feb; 20(1):51-4. PubMed ID: 9020288
[TBL] [Abstract][Full Text] [Related]
17. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer.
Rixe O; Coeffic D; Orcel B; Maitre B; Borel C; Benhammouda A; Petit T; Khayat D; Derenne JP
Am J Clin Oncol; 1997 Apr; 20(2):128-31. PubMed ID: 9124184
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]